English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/150577
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Sample preparation of serum to allow capillary electrophoresis analysis of prostate specific antigen isoforms

AutorFarina-Gomez, Noemi; Barrabés, Silvia; Gomez-Lopez, Jorge E.; González, Mónica; Puerta, Angel de la ; Navarro-Calderon, Diana; Albers-Acosta, Edurado; Olivier, Carlos; Díez-Masa, José Carlos; Peracaula, Rosa; Frutos, Mercedes de
Palabras claveProstate cancer biomarkera
Serum
Sample treatment
Two-dimensional electrophoresis
Capillary electrophoresis
Prostate specific antigen
Fecha de publicación2017
EditorElsevier
CitaciónJournal of Pharmaceutical and Biomedical Analysis 134: 220-227 (2017)
ResumenProstate cancer is the second most frequently diagnosed cancer in men worldwide. Currently prostate specific antigen (PSA) serum concentration is the most used prostate cancer marker, but it only shows limited specificity. Because PSA glycosylation is altered by prostate cancer, detecting glycosylation changes could increase PSA specificity as a prostate cancer marker. Changes in PSA glycosylation can modify its electrophoretic- behavior and techniques such as capillary zone electrophoresis (CZE) and two-dimensional electrophoresis (2-DE) could be applied to detect changes in PSA glycosylation. Most serum PSA is complexed with alpha-1 antichymotrypsin (ACT). To have access to most of the PSA, the complexed PSA has to be released as free PSA (fPSA); in addition, this total fPSA must be purified from the serum matrix so that it can be analyzed using CZE. In this work a methodology for isolating PSA from serum for its CZE analysis was established. By using PSA standard, the effect of this methodology, which combines conditions for dissociating complexed PSA and immunoaffinity chromatographic purification, was studied. It was seen that this highly repeatable sample treatment did not noticeably alter the circular dichroism (CD) spectrum or the CZE pattern of PSA standard. Therefore, as a proof-of-concept, the developed sample treatment was applied to serum from a cancer patient with a high PSA content. The following observations can be made from these experiments: first of all, the 2-DE pattern of serum PSA remained unchanged after sample treatment; second, as hypothesized, the established sample preparation methodology made it possible to obtain the CZE pattern of PSA from serum; and third, the CZE pattern of serum PSA and of PSA standard from seminal plasma of healthy individuals, both submitted to the sample treatment method, showed some differences regarding the proportion of CZE peaks of the glycoprotein. These differences could be related to possible changes in the linkages of peptide backbone, in glycosylation or in other post-translational modifications between samples from both origins.
Versión del editorhttp://dx.doi.org/10.1016/j.jpba.2016.11.045
URIhttp://hdl.handle.net/10261/150577
DOI10.1016/j.jpba.2016.11.045
Identificadoresdoi: 10.1016/j.jpba.2016.11.045
issn: 0731-7085
e-issn: 1873-264X
Aparece en las colecciones: (IQOG) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.